Breast Cancer Medicine — Treatment Options Explained for Patients in Hyderabad

Breast cancer medicine is a broad term for any systemic treatment — meaning treatment that travels through the bloodstream to reach cancer cells anywhere in the body. It includes several categories: chemotherapy (which targets rapidly dividing cells), hormone-blocking therapy (which starves hormone-sensitive tumours of oestrogen or progesterone), targeted therapy (which blocks specific proteins that help cancer cells grow), and immunotherapy (which helps your immune system recognise and attack cancer). Your oncologist will recommend one or more categories based on your tumour's receptor status, stage, and overall health. Not every patient needs all categories.

Yes — for some patients, oral tablets are the main form of treatment rather than chemotherapy infusions. Hormone-blocking therapy (for ER/PR-positive cancers) is typically given as a daily tablet taken for five to ten years. Some forms of targeted therapy are also oral tablets. Whether a tablet-based approach is right for you depends on your cancer's receptor profile, stage, and biology — your CION tumor board will review your full pathology report before deciding. Patients who do need chemotherapy usually receive it as an infusion; however, oral chemotherapy forms exist for certain situations too.

Duration varies by treatment category. Chemotherapy is typically given in cycles — often four to eight cycles spread over three to six months. Hormone-blocking therapy (for hormone receptor-positive breast cancer) usually continues for five to ten years because it works silently in the background to reduce the chance of the cancer returning. Targeted therapy duration depends on which specific pathway it addresses and whether it is given alongside other treatments. Your oncologist will map out a clear timeline at your first consultation so you always know where you are in the journey.

All breast cancer medicine categories can have side effects, though they differ by type. Chemotherapy commonly causes temporary hair loss, fatigue, nausea, and reduced immunity. Hormone-blocking tablets may cause joint stiffness, hot flushes, and changes in bone density over long-term use. Targeted therapy side effects depend on the specific pathway targeted. Immunotherapy can occasionally trigger immune-related inflammation. CION's allied care team — including a dietitian, psycho-oncologist, and physiotherapist — works alongside your oncologist to actively manage side effects, not just document them. We review your wellbeing at every visit.

CION Cancer Clinics accepts Aarogyasri (for eligible government beneficiaries in Telangana), CGHS, ECHS/EHS (for defence and state government employees), and most major private insurance policies on a cashless basis. We also offer no-cost EMI options for patients who prefer to spread treatment costs. Our patient-support team will check your eligibility, complete the pre-authorisation paperwork, and explain all costs clearly before treatment begins — no surprises, transparent billing.

The right choice depends on several test results: your tumour's hormone receptor status (ER, PR), HER2 status, Ki-67 proliferation index, stage, lymph node involvement, and your overall health. At CION, every newly diagnosed patient goes through a tumor board — a meeting of medical, surgical, and radiation oncologists who review your complete report together. You are never given a treatment plan by a single doctor alone. The board reaches a consensus recommendation, then a senior oncologist explains it to you personally in a 45-minute consultation. You decide when you feel ready.